India Glycols is trading 5.18% up now at INR 1159.00 after receiving the certified NCLT order on August 20, 2026, formally clearing its three-way demerger.

  • The restructuring creates India Glycols, IGL Spirits, and Ennature Bio Pharma, offering shareholders separate exposure to chemicals, spirits and biofuels, and biopharma businesses.
  • Q1 FY27 profit rose 32.2% year over year to ₹96.8 crore, supporting renewed value-unlocking expectations.